Efficacy and safety of peginterferon alpha monotherapy in Chinese inactive chronic hepatitis B virus carriers.
Fengping WuRui LuYixin LiuYikai WangYan TianYaping LiMei LiWenjun WangXin ZhangXiaoli JiaShuangsuo DangPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
Peg-IFN-α monotherapy results in high rates of HBsAg clearance and seroconversion and the treatment is safe for IHCs.